Gsa Capital Partners LLP Genocea Biosciences, Inc. Transaction History

Gsa Capital Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.06 - $2.82 $166,604 - $228,070	-80,876 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$2.35 - $4.01 $117,192 - $199,974	-49,869 Reduced 38.14%	80,876 $219,000
Q4 2020 Feb 03, 2021	BUY	$1.91 - $2.67 $249,722 - $349,089	130,745 New	130,745 $316,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.